ThaissLab

The path toward using microbial metabolites as therapies | EBioMedicine

IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response | Science Immunology
The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs | Science Translational Medicine

β-Hydroxybutyrate suppresses colorectal cancer | Nature

2022, Highlights

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection | Science

2018, Highlights

Early prediction of decompensation (EPOD) score: Non-invasive determination of cirrhosis decompensation risk | Liver international

2022

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity | Nature

2012
Menu